Evaluating the Safety and Efficacy of Fumonisin Esterase Produced by Saccharomyces cerevisiae NCAIM (P) Y001485 as a Feed Additive for All Pig Species: Insights from EU Assessment
In a recent development, the European Food Safety Authority (EFSA) conducted an assessment of fumonisin esterase, produced by Saccharomyces cerevisiae NCAIM (P) Y001485, as a feed additive for all pig species. The evaluation aimed to determine the safety and effectiveness of this enzyme in reducing mycotoxin contamination in pig feed. This article provides an overview of the findings from the EFSA evaluation.
Assessment of Safety and Efficacy:
Following a request from the European Commission, the EFSA's Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) reviewed the safety and efficacy of fumonisin esterase as a technological feed additive. The assessment focused on its use in piglets, pigs for fattening, sows, and minor growing and reproductive porcine species.
The expert panel concluded that the additive is safe for weaned and suckling piglets, as well as pigs for fattening. The recommended dosage of the additive in complete feed for all minor growing porcine species should not exceed 60 U/kg. However, no definitive conclusions could be drawn regarding the safety of the additive in sows.
The evaluation also indicated that the use of fumonisin esterase as a feed additive at the minimum recommended concentration of 60 U/kg effectively reduces fumonisin contamination in feed. This conclusion can be extended to all growing and reproductive pigs, as well as other minor porcine species.
Consumer Safety and Environmental Considerations:
The EFSA assessment emphasized that the use of the additive in animal nutrition does not pose any concerns for consumer safety. It was determined that the additive is dust-free and unlikely to cause respiratory sensitization or irritation. Furthermore, the additive was found to be non-irritating to the eyes and skin, although further investigation is required regarding skin sensitization. The evaluation also concluded that the use of the additive as a feed additive is considered safe for the environment.
The EFSA evaluation of fumonisin esterase produced by Saccharomyces cerevisiae NCAIM (P) Y001485 as a feed additive for all pig species provides valuable insights into its safety and efficacy. The additive was deemed safe for weaned and suckling piglets, as well as pigs for fattening, with the recommended dosage not exceeding 60 U/kg in complete feed. However, further research is required to determine the safety of the additive in sows. The evaluation also highlighted the effectiveness of the additive in reducing fumonisin contamination in pig feed. These findings contribute to the understanding of feed safety and support the responsible use of additives in animal nutrition.
2026-10-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Korea Unlocks Additive Flexibility: New Rules Broaden Food Ingredient Horizons
-
Japan Tightens Tap: Pesticide Limits in Drinking Water Get a Safety Overhaul
-
Uganda Sets Sugar Standards: East African Drafts Define Sweetness and Safety
-
Thailand Clears the Path for Vitamin Use: Streamlined Approval for Supplements
-
Solvay's "Slimming Action": Soda Ash Production Capacity in Spain Slashed by 180,000 Tons, 77 Jobs to Go
-
Wacker Under Global Cost Pressure: Dual-Track Restructuring Through Layoffs, Consolidation, and Strategic Repositioning
-
Saudi Aramco Weighs Discounts of Up to $9/Barrel on Oman STS Crude as Freight Costs Surge
-
Honeywell Acquires Johnson Matthey Catalyst Business at a Discount, Cutting £475 Million from the Price
-
India Swings the Tariff Axe at Made-in-China: Epoxy Resins Are Just the Beginning—The Road for Chinese Chemicals Abroad Is No Longer Smooth
-
Japan Begins Construction of the World’s Largest Commercial Liquid Hydrogen Receiving Terminal
Recommend Reading
-
LG Chem Enters Semiconductor Stripper Market for the First Time, Cutting Process Time by 50%
-
New Ocean Freight GRI Takes Effect on Asia, Middle East and Africa Routes to U.S. and Canada
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
Private Equity Firm Acquires Lyons Magnus for About $1 Billion as Beverage and Nutrition Ingredients Consolidate
-
Expectations of Tightening Supply Dominate the Recovery in Formic Acid Prices
-
Business Society’s Market Outlook for MIBK on August 11, 2026: Tending to Weak
-
Key Events in the Epoxy Resins Industry in February 2026
-
Cost Side Remains Strong; ABS Rises Along with Upstream Prices at End of January
-
Premium Global Chemical Sourcing Requests (23 - 27 Feb, 2026)